NYSE · SIC 3841
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $8.1B | $8.2B | $8.3B | $8.3B |
| Gross profit | $4.7B | $4.7B | $4.6B | $4.5B |
| Operating income | $1.7B | $1.7B | $1.0B | $2.2B |
| Net income | $1.3B | $1.3B | $479.0M | $1.6B |
| Diluted EPS | $7.78 | $7.79 | $2.76 | $8.88 |
| Operating cash flow | $1.7B | $1.9B | $1.2B | $369.0M |
| Free cash flow | $1.4B | $1.6B | $805.0M | -$10.0M |
| Gross margin | 57.7% | 57.3% | 55.6% | 53.5% |
| Operating margin | 20.8% | 20.6% | 12.6% | 26.2% |
| Net margin | 16.5% | 16.4% | 5.8% | 18.7% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.1B | $2.1B | $2.1B | $2.1B | $2.2B | $2.1B | $2.0B | $2.0B |
| Gross profit | $1.1B | $1.2B | $1.1B | $1.1B | $1.2B | $1.1B | $1.0B | $1.1B |
| Operating income | $244.0M | $275.0M | $136.0M | $152.0M | $214.0M | $1.7B | $125.0M | $81.0M |
| Net income | $89.0M | $122.0M | $31.0M | $137.0M | $90.0M | $1.3B | $63.0M | $13.0M |
| Diluted EPS | $0.51 | $0.70 | $0.18 | $0.78 | $0.51 | $7.22 | $0.37 | $0.07 |
| Operating cash flow | $355.0M | $169.0M | $219.0M | $29.0M | $169.0M | $76.0M | $95.0M | -$189.0M |
| Free cash flow | $297.0M | $76.0M | $92.0M | -$80.0M | $59.0M | -$21.0M | $32.0M | -$273.0M |
| Gross margin | 54.6% | 56.0% | 53.9% | 53.8% | 54.4% | 54.2% | 51.4% | 54.7% |
| Operating margin | 11.7% | 13.2% | 6.6% | 7.3% | 9.9% | 80.6% | 6.3% | 4.0% |
| Net margin | 4.3% | 5.9% | 1.5% | 6.6% | 4.2% | 60.4% | 3.2% | 0.6% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-13 | Hanson Bryan C· Chief Executive Officer | Tax withholding | 13,503 | $74.41 | $1.0M | filing |
| 2026-05-13 | McMillan Wayde D.· Chief Financial Officer | Tax withholding | 4,404 | $74.41 | $327,701.64 | filing |
| 2026-05-13 | Landucci Amy· Chief Information Officer | Tax withholding | 2,017 | $74.41 | $150,084.97 | filing |
| 2026-05-13 | Kirberger Marcela A.· Chief Legal Affairs Officer | Tax withholding | 1,952 | $74.41 | $145,248.32 | filing |
| 2026-05-13 | Harrington Paul S· Chief Supply Chain Officer | Tax withholding | 1,678 | $74.41 | $124,859.98 | filing |
| 2026-05-13 | Gomez Tammy L· Chief Human Resources Officer | Tax withholding | 1,668 | $74.41 | $124,115.88 | filing |
| 2026-05-13 | Wilcox Mary T· Chief Accounting Officer | Tax withholding | 728 | $74.41 | $54,170.48 | filing |
| 2026-05-13 | Kirberger Marcela A.· Chief Legal Affairs Officer | Option exercise | 4,488 | $0.00 | $0.00 | filing |
| 2026-05-13 | Gomez Tammy L· Chief Human Resources Officer | Option exercise | 3,960 | $0.00 | $0.00 | filing |
| 2026-05-13 | Hanson Bryan C· Chief Executive Officer | Option exercise | 34,315 | $0.00 | $0.00 | filing |
| 2026-05-13 | Harrington Paul S· Chief Supply Chain Officer | Option exercise | 3,960 | $0.00 | $0.00 | filing |
| 2026-05-13 | Landucci Amy· Chief Information Officer | Option exercise | 4,422 | $0.00 | $0.00 | filing |
| 2026-05-13 | Wilcox Mary T· Chief Accounting Officer | Option exercise | 2,376 | $0.00 | $0.00 | filing |
| 2026-05-13 | McMillan Wayde D.· Chief Financial Officer | Option exercise | 9,503 | $0.00 | $0.00 | filing |
| 2026-04-30 | Harris Bernard A Jr | Option exercise | 3,403 | $0.00 | $0.00 | filing |
| 2026-04-30 | Wendell Amy McBride | Option exercise | 3,403 | $0.00 | $0.00 | filing |
| 2026-04-30 | WEILAND JOHN H | Option exercise | 3,403 | $0.00 | $0.00 | filing |
| 2026-04-30 | Mily Elizabeth | Option exercise | 3,403 | $0.00 | $0.00 | filing |
| 2026-04-30 | Wilson Darryl L. | Option exercise | 3,403 | $0.00 | $0.00 | filing |
| 2026-04-30 | MAY KAREN J | Option exercise | 3,403 | $0.00 | $0.00 | filing |
| 2026-04-30 | EISENBERG GLENN A | Option exercise | 3,403 | $0.00 | $0.00 | filing |
| 2026-04-30 | Edwards Shirley Ann | Option exercise | 3,403 | $0.00 | $0.00 | filing |
| 2026-04-30 | DeVore Susan D. | Option exercise | 3,403 | $0.00 | $0.00 | filing |
| 2026-04-30 | COX CARRIE SMITH | Option exercise | 4,916 | $0.00 | $0.00 | filing |
| 2026-04-30 | ALBAN CARLOS | Option exercise | 3,403 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.